A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation of Mass Drug Administration

• Ramakrishna U. Rao,

  Affiliation Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Kumara C. Nagodavithana,

  Affiliation Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka

  ⨯
• Sandhya D. Samarasekera,

  Affiliation Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka

  ⨯
• Asha D. Wijegunawardana,

  Affiliation Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka

  ⨯
• Welmillage D. Y. Premakumara,

  Affiliation Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka

  ⨯
• Samudrika N. Perera,

  Affiliation Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka

  ⨯
• Sunil Settinayake,

  Affiliation Anti Filariasis Campaign, Sri Lanka Ministry of Health, Colombo, Sri Lanka

  ⨯
• J. Phillip Miller,

  Affiliation Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Gary J. Weil

  * E-mail: gweil@dom.wustl.edu

  Affiliation Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯